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Abstract
Purpose The purpose of this study was to evaluate ultra high
density-activation sequence mapping (UHD-ASM) for ablat-
ing atypical atrial flutters.
Methods For 23 patients with 31 atypical atrial flutters (AAF),
we created UHD-ASM.
Results Demographics age = 65.3 ± 8.5 years, male = 78%,
left atrial size = 4.66 ± 0.64 cm, redo ablation 20/23(87%).
AAF were left atrial in 30 (97%). For each AAF, 1273 ± 697
points were used for UHD-ASM. Time to create and interpret
the UHD-ASM was 20 ± 11 min. For every AAF, the entire
circuit was identified. Thirty (97%) were macroreentry. AAF
cycle length was 267 ± 49 ms, and the circuit length was 138
± 38 mm (range 35–187). Macroreentry atrial flutters took
varied pathways, but each had an area of slow conduction
(ASC) averaging 16 ± 6 mm (range 6–29) in length.
Entrainment was not utilized. We targeted the ASC and abla-
tion terminated AAF directly in 19/31 (61.3%) and altered
AAF activation in 7/31 (22.6%), all of which terminated di-
rectly with additional mapping/ablation. AAF degenerated to
atrial fibrillation in 2/31 (6.5%) with RF and could not be
reinduced after ASC ablation. Median time from initial abla-
tion to AAF termination was 64 s. Thus, 28/31 (90.3%)
terminated with RF energy and/or could not be reinduced after
ASC ablation. At 1 year of follow-up, 77% were free of atrial
tachycardia or atrial flutter and 61% were free of all atrial
arrhythmias.
Conclusions Using rapidly acquired UHD-ASM, the entire
AAF circuit as well as the target ASC could be identified.
Most AAF were left atrial macroreentry. Ablation of the
ASC ormicroreentry focuses directly terminated or eliminated
AAF in 90.3% without the need for entrainment mapping.
Keywords Atrial flutter . Atrial flutter ablation . Activation
mapping . Atypical atrial flutter . Left atrial flutter
1 Introduction
For decades, there was a scientific debate as to whether or not
typical atrial flutter was focal or reentrant [1, 2]. With the
introduction of newer computer-driven mapping systems, it
became clear that the vast majority of typical atrial flutters
were reentrant and involved the right atrial caval-tricuspid
isthmus in either a counterclockwise or clockwise rotational
pattern. Atypical atrial flutters, however, have proven more
challenging to map and ablate [3–9]. Many of these atrial
flutters occur in patients who have undergone previous med-
ical procedures such as valvular or congenital cardiac surgery
involving atriotomy, surgical Maze operations, or pulmonary
vein isolation procedures. Mapping and ablation of these com-
plex arrhythmias continue to be a challenge for clinical elec-
trophysiologists. A combination of activation sequence map-
ping and entrainment [10] has commonly been utilized to
understand and ablate these arrhythmias. In this study, we
report our experience with the use of ultra high density-
activation sequence mapping (UHD-ASM) to determine the
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The subjects were symptomatic patients undergoing ablations
for atypical, non-right atrial isthmus-dependent flutter at
Sequoia Hospital, Redwood City, CA, from October 4, 2013
to October 21, 2014. All signed the written informed consent.
Data analysis was retrospective and approved by the Western
Institutional Review Board.
2.2 Ablation protocol
Our ablation protocol has been described previously [11].
Antiarrhythmic drugs were stopped at least five half-lives
and amiodarone at least 3 months before ablation. General
anesthesia was used in all, and venous access was from the
right groin only. A 9F Boston Scientific (Natick, MA) Ultra
Ice™ catheter guided the transseptal puncture, done using a
71-cm Baylis (Montreal, QC) NRG™ needle. The mapping
and ablation catheters were both placed in the left atrium
across a single transseptal puncture. All ablations were done
using a Safire™BLU™ (St JudeMedical, St. Paul, MN) open
irrigated tip ablation catheter at 50 W. Patients had a femoral
or radial arterial line. Our peri-procedural anticoagulation pro-
tocols have also been previously described [12].
2.3 Mapping protocol
3D geometry and mapping were done using the St. Jude
EnSite Velocity system with Precision Mapping Module. A
7F 20 electrode catheter (St. Jude Livewire™, 2-10-2 mm
electrode spacing catheter) was placed around the tricuspid
valve annulus with the distal poles in the coronary sinus.
Following access to the left atrium, a 3D geometry was creat-
ed. Patients who were in their clinical atrial arrhythmia at the
start of the case had activation mapping simultaneous with
geometry creation. A stable atrial bipolar electrogram, prefer-
ably from an electrode pair inside the coronary sinus, was
chosen as an activation mapping reference and a reference
detection algorithm was chosen to ensure consistent detection
and timing of the reference electrogram. A surface ECGwith a
visible atrial flutter wave was added to the mapping window
to confirm stability of the reference electrogram relative to the
atrial flutter wave. The left edge of the mapping window was
set at 60 ms ahead of the onset of the most prominent atrial
flutter wave on the surface ECG, and the right edge of the
mapping window was set so that at least 95% of the tachycar-
dia cycle length was encompassed within the mapping
window. Timing within the arrhythmia cycle length was di-
vided into eight equal parts, each tagged with a different color
to create an isochronal color map. These color maps are sim-
ilar to traditional isochronal maps where lines are drawn to
reflect zones of similar activation times. The only difference
was that there are no lines drawn between the various colors.
Slower conduction is indicated by a narrowing of the width of
the individual color zones or a compression of the colors. A
circular mapping catheter (St. Jude Reflexion Spiral™) with
20 electrodes, and a 15–25 mm variable loop was used as a
roving mapping catheter. The bipolar electrograms were re-
corded from 1 mm electrodes (except for the tip which is
2 mm) separated by 1 mm. Up to 10 simultaneously collected
bipolar electrograms were obtained at each anatomical posi-
tion of the roving catheter. The detection setting was config-
ured to automatically detect the largest amplitude bipolar
peak, and the sensitivity was set to the maximum of 10 mV.
This combination allowed the computer to detect and annotate
the largest amplitude bipolar peak in the mapping window
regardless of the voltage. In the case of double potentials or
fractioned electrograms within an area of interest, the user
could manually override the automatic detection to annotate
the timing of the said point to the peak of the sharpest near-
field component of the signal. Using this method of collecting
a high density of points with a multipolar mapping catheter,
the need for this manual annotation is generally minimal.
However, when delineating activation in areas of dense scar
and mapping locations was prone to high amplitude far-field
signals, such as the anterior left superior pulmonary vein
which often also has right atrial signals or the AV groove
which often also has ventricular signals, manual editing may
still be necessary.
The low voltage identification level was set to 0.1 mV ini-
tially to allow low voltage zones to be collected and displayed
as gray colored low voltage zones on the map. This helped to
prevent inaccurate timing measurements when sampling from
regions of scarred or non-conductive tissue.
Following the appropriate setting of all map values, the first
set of activation mapping points were collected from the cor-
onary sinus reference catheter to store the map settings as well
as the reference catheter activation sequence for the atrial ar-
rhythmia. This allowed a set of waveform shadows to be vi-
sualized behind the live coronary sinus catheter electrograms.
If a change occurred in the intracardiac activation sequence,
these shadows helped the user identify that a rhythm change
had taken place or that the reference catheter had moved.
When either no anatomical surface model had been created
or the mapping catheter was in a new area of the chamber that
had not previously had geometry created, anatomical static
shell points and activation mapping points were collected si-
multaneously. While the roving circular catheter was being
moved throughout the chamber, the mapping system rapidly
acquired 10 activation points at a time. During rapid
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acquisition, the operator monitored the signals to eliminate
collection of points with noise or ventricular signal. When
the full chamber was mapped, field scaling was applied, the
geometry was edited and completed, and the activation map
was projected onto the geometry surface to evaluate the ar-
rhythmia circuit. Mapping points not in close proximity to the
static model geometry surface were excluded from the analy-
sis. This eliminated any far-field electrograms collected inside
the chamber from being used to create the activation map of
the atrial arrhythmias. Both color isochronal and propagation
maps were generated. If any areas of interest in the chamber
were determined to be under-sampled, additional points were
added to the activation map as deemed necessary. This was
most often needed in the areas of slowest conduction. In a
highly diseased atrial chamber, or to determine the activation
sequence through the areas of slow conduction, the low volt-
age level was adjusted to as low as 0.03 mV for visualization
of low-amplitude signals within the areas of scar. The circuit
of each macroreentrant atrial flutter was measured by tracing
the leading edge of each color isochronal zone. Although we
used eight color isochrones during the clinical studies, during
post hoc evaluation of the circuit, we sometimes used 15 and
22 isochrones to more accurately define the atrial flutter cir-
cuit. This allowed measurement of the total length of the atrial
flutter circuit. The area of slowest conduction was determined
for each atrial flutter, and the length of the slow zone and time
of conduction through this zone were determined.
Microreentrant atrial flutter or focal atrial tachycardia was
defined as an arrhythmia where the origin of the arrhythmia
occurred in a very small area (<1 cm) and radiated outward
from that site. At the end of each ablation, all pulmonary veins
were checked tomake certain that theywere isolatedwith both
entrance and exit block and any which were still connected
were re-ablated to complete PV isolation. Arrhythmia induc-
tion with and without isoproterenol was undertaken until all
inducible organized atrial arrhythmias had been mapped an
ablated.
2.4 Data collection and analysis
For each patient, we recorded age, gender, duration of AF or
atrial flutter, prior antiarrhythmic drug therapy, CHADS2 and
CHA2DS2-VASC score, cardioversions, body mass index, left
atrial (LA) size, prior strokes/TIA’s, and the presence of hy-
pertension, coronary artery disease, and dilated cardiomyopa-
thy. A successful ablation was defined as no AF, atrial flutter,
or tachycardia lasting more than 30 s off of all antiarrhythmic
drugs after a 3-month blanking period.
2.5 Follow-up
Some patients were treated with antiarrhythmic drugs and/or
cardioverted during the 3 months following the ablation.
Patients sent daily transtelephonic ECG strips for 1–3 months
after ablation and were seen at 3 and 12months, at which time
7–14 days of continuous monitoring using a ZIO patch
(iRhythm Technologies, Inc., San Francisco, CA) was done.
Thereafter, patients were seen directly or contacted by phone
at least annually and arrhythmia records were obtained from
the hospitals and referring physicians. ECG recorders were
reissued for any arrhythmia symptoms. Pacemaker AF data
were utilized when available.
2.6 Data analysis
Continuous data were described as mean ± standard deviation
and counts and percent if categorical. Kaplan-Meier curves
were generated for freedom from all atrial arrhythmias and
for freedom from atrial tachycardia and atrial flutter after the
ablation using XLStat, 2015 (Paris, France).
3 Results
3.1 Patient population
The population consisted of 23 patients with atypical atrial
flutters. The average age was 65.3 ± 8.5 years and 78% were
male. The demographics are shown in Table 1. Twenty-one
patients (91.3%) had undergone either prior left atrial ablation
or a surgical maze procedure. The 21 patients with a prior left
atrial ablation or surgical maze procedure had a total of 82
pulmonary veins. Only 24 of the 82 (29.2%) remained isolated
from their previous procedure. Only three patients (9.5%) had
all pulmonary veins isolated, and three patients (14.2%) had
three of four pulmonary veins isolated. The two patients who
Table 1 Clinical characteristics
Number of patients 23
Left atrial size (cm) 4.66 ± 0.64 (3.7–5.4)
Age (years) 65.3 ± 8.5 (47–77)
Body mass index 29.8 ± 4.5 (23.5–40.8)
Gender: female 22.0%
# without prior ablation or MAZE 2 (8.7%)
Duration of AF (years) 5.7 ± 4.8 (0.5–19)
# Drugs failed 1.56 ± 1.16 (0–4)
CHADS2 score 2.17 ± 1.23 (0–5)




Coronary artery disease 26.1%
Dilated cardiomyopathy 8.7%
Ranges in parentheses
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had not undergone one of these procedures included one
patient with a lamin AC cardiomyopathy and severe atrial
fibrosis and one with a prior aortic valve replacement. Atrial
fibrillation or atrial flutter had been present for 5.7 ± 4.8 years.
The average left atrial size was 4.66 ± 0.64 cm. Structural
heart disease was present in 34.8% of patients.
3.2 Mapped arrhythmias
A total of 31 sustained and organized atrial arrhythmias were
either present clinically or induced during the study. These
were macroreentrant arrhythmias in 97% and microreentrant
or focal in 3%. The left atriumwas involved in 30 of 31 (97%)
of the arrhythmias. The average cycle length for the atrial
arrhythmias was 267 ± 49 ms (range 206–444). The total
length of the atrial flutter circuit for the 30 macroreentrant
arrhythmias was 138 ± 38 mm (range 35–187). Each of the
macroreentrant arrhythmias had a distinct area of slow con-
duction. The length of the area of slow conduction was 16 +
6 mm (range 6–29), and the conduction time through the slow
zone was 92 ± 49 (range 33–247) ms. The length of the re-
mainder of the atrial flutter circuit was 122 ± 36 mm (range
29–164), and the conduction time in the remaining zone was
175 ± 45 (range 88–256) ms. The location of the area of slow
conduction or microreentry circuit was right atrium = 1, LA
roof = 5, LA anteroseptal = 4 (Fig. 1 and Appendix 1), LA
posterior = 2, LA/pulmonary vein ridge = 2 (Fig. 2 and
Appendix 2), complete mitral isthmus = 4, complex mitral
isthmus (where part of the circuit was around the mitral isth-
mus but the rest was around other parts of the atrium) = 11
(Fig. 3 and Appendix 3), and involved reentry going in and
out of one of the pulmonary veins in 2.
3.3 Mapping data and arrhythmia termination
The total number of points collected for each atrial arrhythmia
mapped was 3815 ± 2576 (357–10,069). The total number of
points utilized to create the map was 1273 ± 697 (range 259–
2959). The difference in points collected and points used was
due to the exclusion of points not in close proximity to the 3D
geometry shell. For patients already in atrial flutter at the start
of the case, the time from initiation of geometry creation to
first RF delivery was 24 ± 11 min. For patients where the
arrhythmia was induced after the geometry was created, the
time from the start of the map to the first RF energy delivery
was 20 ± 11 min for each flutter mapped. Twenty-eight of 31
atrial flutters terminated when ablating the slow zone or
microreentry or focal site (90.3%). Nineteen of 31 (61.3%)
converted directly to sinus rhythm. Seven of 31 (22.6%)
changed into another atrial flutter circuit which was mapped
and then terminated directly to sinus rhythm with additional
ablation. Two of 31 (6.5%) degenerated from atrial flutter into
atrial fibrillation during ablation of the area of slow conduc-
tion and required cardioversion. Those atrial flutters could not
be reinduced. The median time from first RF to termination of
the arrhythmia was 64 s (range 3–2134 s). A single patient
with the extremely long time of 2134 s to termination of the
arrhythmia ultimately had their arrhythmia terminated a few
millimeters from where we started the first ablation. The time
from first RF to atrial flutter termination was less than 1 min in
Fig. 1 Left atrial anteroseptal flutter with an area of slow conduction
between the septal scar and a previously isolated right superior
pulmonary vein. (RSPV right superior pulmonary vein, RIPV right
inferior pulmonary vein, LSPV left superior pulmonary vein, LAA left
atrial appendage). See Appendix 1 for the propagation map of this atrial
flutter
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13 of 27 cases (48.1%) and was less than 4 min in 21 of 27
(78%). There were no procedural complications in any
patients.
3.4 Follow-up
Figure 4 shows the Kaplan-Meier follow-up curve for free-
dom from atrial tachycardia and atrial flutter(top panel) and
freedom from all atrial arrhythmias lasting more than 30 s
(bottom panel) off of antiarrhythmic drugs following ablations
for atypical atrial flutter. At 1 year, 77% were free of atrial
tachycardia and atrial flutter and 61% were free of all atrial
arrhythmias. Among the 10 patients who had atrial arrhythmia
recurrence, the failure rhythm was atrial fibrillation in 4 pa-
tients and atrial flutter in 6 patients. One of the patients had a
repeat procedure, and the atrial flutter was utilizing a different
circuit than the one ablated at the index procedure. For the
other five patients, as best we could determine from available
ECGs, the atrial flutters did not appear to be the ones we had
ablated at the index procedure. However, without detailed
Fig. 2 Double loop left atrial flutter with anterior loop going clockwise
along the inferior mitral annulus and up the septum and the posterior loop
going counterclockwise around the left pulmonary veins with a common
segment of slow conduction between the left atrial appendage and the left
inferior pulmonary vein. (LIPV left inferior pulmonary vein, other
abbreviations as in Fig. 1). See Appendix 2 for the propagation map of
this atrial flutter
Fig. 3 Complex mitral isthmus flutter. Much of the atrial flutter circuit is
around the mitral valve. However, the circuit deviates toward the critical
area of slow conduction between LAA and the LIPV. It then returns to the
mitral valve via conduction through the LAA. Abbreviations as in Figs. 1
and 2. See Appendix 3 for the propagation map of this atrial flutter
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intracardiac mapping, it is difficult to be certain that these
were indeed different atrial flutters. Two of the patients who
had arrhythmia recurrence off of antiarrhythmic drugs were
free of arrhythmias on an antiarrhythmic drug.
4 Discussion
The main finding of this study is that it is possible, using only
UHD-ASM, to map the entire arrhythmia circuit for most
atypical atrial flutters and to successfully ablate them by
targeting an area of slow conduction. In the past, mapping
these arrhythmias has been done with older and less accurate
mapping systems, limiting the number of data points which
could be collected, and using larger tip ablating catheters with
widely spaced bipolar electrodes resulting in poor resolution.
Entrainment mapping has been utilized as an aid to determin-
ing the location of the atrial flutter circuit. However, entrain-
ment mapping has a number of limitations for mapping these
arrhythmias. Themorphology of the atrial flutter on the surface
ECG is often very low amplitude and it is difficult to compare
the entrained surface lead morphology to the clinical morphol-
ogy. In addition, measurement of the post pacing interval can
be difficult and, at times, entrainment pacing attempts can
either change or terminate the arrhythmia which is being
mapped. It may be difficult to pace in areas of atrial scar which
are part of the atrial flutter circuit or pacing may only be ac-
complished with higher outputs that could distort local signals.
Although entrainment can give an idea of whether or not they
are pacing from within the atrial flutter circuit, it provides
relatively little information with regard to the optimal place
to perform ablation to terminate and eliminate the arrhythmia.
In most instances, atypical atrial flutters can have an UHD-
ASM collected in a very timely manner and the maps do not
require any special catheters, other than a standard circular
mapping catheter. When logistically possible, it would seem
preferable to bring these patients for ablation when they are in
their clinical atrial flutter. This eliminates the possibility of not
being able to induce the clinical atrial flutter or mapping an
induced non-clinical atrial flutter. If the patient is in the ar-
rhythmia at the start of the case, these maps can be obtained at
the same time one is creating the 3D geometry shell.Whatever
additional time is required to create these high density maps is
ultimately made up for by the relatively short time it frequent-
ly takes to effectively ablate them.
4.1 Comparison to prior 3D mapping
There have been prior reports of 3D mapping and ablation of
LA flutters. One of the earliest by Jais et al. [3] evaluated 18
atrial flutters in 17 patients. The mechanisms of the atrial
flutters were similar to our findings. Entrainment mapping
was also used to define the atrial flutter mechanism and cir-
cuit. That study required 39 ± 33 min of RF delivery to termi-
nate the atrial flutters. In contrast, using newer UHD-ASM,
we were able to terminate atrial flutters in a significantly
shorter time. Our median total time elapsed from the start of
first RF delivery to atrial flutter termination was only 64 s,
likely due to a more accurate definition of the entire atrial
flutter circuit and the critical areas of slow conduction for
targeting RF energy application. Another study [7] of left atri-
al arrhythmias also showed a preponderance of macroreentry
as the mechanism. That study relied heavily on entrainment
mapping as well as activation sequence mapping to define the
tachycardia circuit. We found that with UHD-ASM, entrain-
ment mapping was rarely, if ever, required to identify the
arrhythmia mechanism, circuit, and target area for ablation.
Fig. 4 Kaplan-Meier curves for freedom from atrial tachycardia and
flutter (top panel) and freedom from all atrial arrhythmias (bottom
panel) following ablation for atypical atrial flutters
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4.2 Importance of closely spaced mapping electrodes
A recent report by Anter et al. [13] emphasized the importance
of using smaller and closely spaced electrodes to create these
high-density atrial activation maps. They compared maps cre-
ated with a standard irrigated tip ablation catheter with 3.5 mm
distal electrodes separated by 2 mm from a proximal 2 mm
electrode with a center-to-center inter-electrode spacing of
4.75 mm to those obtained with 1 mm electrodes and 2 mm
inter-electrode spacing with a 3 mm center-to-center inter-
electrodes pacing. When mapping healthy atrial tissue, there
was little difference between the two mapping catheters.
However, in atrial scar, the larger electrodes with greater spac-
ing resulted in an overestimation of the area of scar and only
allowed for identification of 68 + 32% of the tachycardia cycle
length compared to identification of 92 + 8% of the tachycar-
dia cycle length with the smaller electrode spacing. Our map-
ping electrode had 1 mm electrodes separated by 1 mm for a
center-to-center internal electrode spacing of 2 mm. This
should provide even better resolution for mapping of the
tachycardia than the electrodes used by Anter et al. [13].
4.3 Long-term outcomes
Although we were highly effective in mapping and ablating
the clinical as well as all induced arrhythmias, the long-term
outcome in these patients with regard to freedom from all
arrhythmias was relatively disappointing.While our definition
of procedural failure includes the occurrence of atrial fibrilla-
tion, others [5] have only included the recurrence of atrial
tachycardias after this type of ablation. Using this definition,
our 1-year success rate would have been 77% rather than 61%.
As best we could determine from available ECG tracings,
none of the mapped and ablated arrhythmias came back.
However, these patients had highly diseased atria with signif-
icant intrinsic scar and scar created at previous procedures
which probably explains the return of other atrial arrhythmias
during follow-up.
4.4 Limitations
This was a single-center study. Patients did not have implant-
able loop recorders after ablation, so we undoubtedly missed
some episodes of asymptomatic atrial arrhythmias during fol-
low-up.
5 Conclusions
Using rapidly acquired UHD-ASM, the entire AAF circuit as
well as a target ASC can be identified. Most AAF were LA
macroreentry. No entrainment mapping was required.
Ablation of the ASC or microreentry focus directly terminated
or eliminated AAF in 90.3% of arrhythmias.
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